Lexeo Therapeutics (LXEO) Accumulated Depreciation (2022 - 2026)
Lexeo Therapeutics (LXEO) reported Accumulated Depreciation of $814000.0 for Q1 2026, up 52.43% on a YoY basis from $534000.0 in Q1 2025, and up 9.85% sequentially from $741000.0 in Q4 2025.
Lexeo Therapeutics (LXEO) Accumulated Depreciation (2022 - 2026) Analysis & Trends
Lexeo Therapeutics (LXEO) has 5 years of Accumulated Depreciation data on file, last reported at $814000.0 in Q1 2026.
- For the quarter ending Q1 2026, Accumulated Depreciation rose 52.43% year-over-year to $814000.0; the trailing twelve-month figure through Mar 2026 stood at $814000.0 (up 52.43% YoY), and the FY2025 full-year result was $741000.0, up 56.33% from the prior year.
- Accumulated Depreciation improved to $814000.0 in Q1 2026, from $741000.0 in the prior quarter.
- In the past five years, Accumulated Depreciation ranged from a high of $814000.0 in Q1 2026 to a low of $133000.0 in Q4 2022.
- A 5-year average of $520333.3 and a median of $530500.0 in 2024 frame the typical range for Accumulated Depreciation.
- Across the five-year window, Accumulated Depreciation surged 186.47% in 2023 and climbed 9.51% in 2025, its largest moves.
- Tracing LXEO's Accumulated Depreciation over 5 years: stood at $133000.0 in 2022, then surged by 186.47% to $381000.0 in 2023, then grew by 24.41% to $474000.0 in 2024, then soared by 56.33% to $741000.0 in 2025, then grew by 9.85% to $814000.0 in 2026.
- Business Quant data shows LXEO's Accumulated Depreciation at $814000.0 in Q1 2026, $741000.0 in Q4 2025, and $668000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Lexeo Therapeutics | 382.38 Mn | 382.38 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 814,000.00 |
| Dec 31, 2025 | 741,000.00 |
| Sep 30, 2025 | 668,000.00 |
| Jun 30, 2025 | 596,000.00 |
| Mar 31, 2025 | 534,000.00 |
| Dec 31, 2024 | 474,000.00 |
| Sep 30, 2024 | 610,000.00 |
| Jun 30, 2024 | 527,000.00 |
| Mar 31, 2024 | 450,000.00 |
| Dec 31, 2023 | 381,000.00 |
| Sep 30, 2023 | 316,000.00 |
| Dec 31, 2022 | 133,000.00 |